Q2 FY27 revenue rises 37%, EBITDA 53% and adjusted profit 109%
ONESOURCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 11.7 pts more than Nifty Smallcap 250 and 11.9 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
For Q2 FY27, revenue was ₹5,162 million, up 37% year on year. EBITDA rose 53% to ₹1,633 million, with margin expanding to 31.6% from 28.3%. Reported profit was ₹575 million, up 448%, while adjusted profit was ₹937 million, up 109%. Adjusted profit excludes ₹18 million in exceptional items and ₹344 million in amortisation. New capacity and launches drove growth. FY2028 targets of $400 million revenue and $160 million EBITDA were reaffirmed.
Strong growth, wider margins and added capacity support positive sentiment; execution on launches and FY28 targets remains the main watchpoint.